Loading clinical trials...
Loading clinical trials...
This trial is conducted in North America, Europe, Asia and Oceania. The purpose of this study is to evaluate safety and efficacy of Recombinant Factor VIIa in patients with acute intracerebral bleedin...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Novo Nordisk A/S
NCT07237048 · Stroke, Ischemia Stroke, and more
NCT07414732 · Stroke, Intracerebral Haemorrhage, and more
NCT07208097 · Intracerebral Haemorrhage, Minimally Invasive Treatment
NCT04712591 · Traumatic Brain Injury, Intracerebral Haemorrhage, and more
NCT07088250 · Cerebrovascular Disorders, Intracranial Hemorrhages, and more
Novo Nordisk Investigational Site
Melbourne
Novo Nordisk Investigational Site
Graz
Novo Nordisk Investigational Site
Antwerp
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions